ArticleBMC psychiatry2026
The relationship between social media addiction and metacognitions in patients with social anxiety disorder.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMental health problems including depression, eating disorders and anxiety disorders are associated with extensive social media use. The literature has examined the relationship between social anxiety and social media addiction; however, there is a lack of studies conducted in clinical patient populations. This study aimed to investigate the role of metacognitions related to social media addiction in individuals diagnosed with social anxiety disorder (SAD).
methodsIn this cross-sectional case-control study, 99 participants aged 18-65 years with social anxiety disorder and 113 control participants were recruited. One control participant with missing BSMAS data was excluded from all analyses, including sociodemographic comparisons; therefore, the final analytic sample included 99 SAD participants and 112 control participants without current psychiatric disorder. The SCID-5 was administered to participants in the SAD group to confirm the diagnosis of social anxiety disorder and to control participants to screen for current psychiatric disorders. No current psychiatric disorder was identified among control participants at the time of assessment. After written informed consent was obtained, all participants completed the Bergen Social Media Addiction Scale (BSMAS), Liebowitz Social Anxiety Scale (LSAS), and Metacognitions Questionnaire-30 (MCQ-30).
resultsSMA prevalence did not differ significantly between participants with SAD and control participants without current psychiatric disorder (52.5% vs. 46.4%; χ²=0.781, p = 0.377; φ = 0.06). Within the SAD group, SMA was associated with higher negative metacognitive beliefs, particularly uncontrollability of worry and the need to control thoughts, and BSMAS severity correlated with these metacognitive domains. Among participants meeting the operational SMA criterion, those with SAD showed higher MCQ-30 uncontrollability of worry scores than control participants. Sensitivity analyses using an alternative BSMAS threshold showed the same overall pattern (see Table 8).
conclusionSMA prevalence was comparable between participants with SAD and control participants without current psychiatric disorder; however, within SAD, problematic social media use was associated with negative metacognitive beliefs. These cross-sectional findings suggest that metacognitive beliefs may be treatment-relevant correlates of problematic social media use in SAD; longitudinal and interventional studies are needed. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.